Ligand Pharmaceuticals Incorporated
CIK 886163 · View on SEC EDGAR ↗
First SEC filing: May 1, 2026 · Latest: May 1, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 26, 2020 | LGND | S | 148,700 | $8.11 | $1,205,957 | 5,819,383 Direct | -2.49% | Disposed | 5619.1% (price as of 2026-08-21) |
| Aug. 26, 2020 | LGND | S | 94,488 | $8.11 | $766,298 | 5,819,383 Direct | -1.60% | Disposed | 5619.1% (price as of 2026-08-21) |
| Aug. 25, 2020 | LGND | S | 70,000 | $8.02 | $561,400 | 5,968,083 Direct | -1.16% | Disposed | 5683.3% (price as of 2026-08-21) |
| Sept. 25, 2018 | LGND | S | 262,881 | $19.15 | $5,034,171 | 6,038,083 Direct | -4.17% | Disposed | 2322.0% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 17, 2025 | LGND | Senior Secured Convertible Note | Common Stock | $29.73 | Nov. 6, 2027 | — | Acquired |
| Dec. 17, 2025 | LGND | Senior Secured Convertible Note | Common Stock | $34.44 | Nov. 6, 2027 | — | Disposed |
| Nov. 6, 2025 | LGND | Senior Secured Convertible Note | Common Stock | $34.44 | — | — | Acquired |
| July 1, 2025 | LGND | Series A Convertible Preferred Stock | Common Stock | — | — | 31,279 | Acquired |
| July 1, 2025 | LGND | Series A Convertible Preferred Stock | Common Stock | — | — | 15,000 | Disposed |
| May 21, 2018 | LGND | Convertible Note (convertible into Common Stock) | Common Stock | — | — | 1,916,509 | Disposed |
| July 13, 2017 | LGND | Convertible Note (convertible into Common Stock) | Common Stock | — | — | 38,630 | Disposed |
| April 13, 2016 | LGND | Convertible Note (convertible into Common Stock) | Common Stock (240,000) | — | — | 150,000 | Disposed |
| April 13, 2016 | LGND | Warrant (right to buy) | Common Stock (960,000) | $1.50 | April 13, 2021 | 960,000 | Acquired |
| April 13, 2016 | LGND | Convertible Note (convertible into Common Stock) | Common Stock (960,000) | — | — | 600,000 | Disposed |
| April 13, 2016 | LGND | Warrant (right to buy) | Common Stock (560,000) | $1.50 | April 13, 2021 | 560,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 3, 2025 | LGND | Series A Convertible Preferred Stock→ Common Stock | — | Direct |
| Sept. 30, 2022 | LGND | Common Stock | 1,000 | Direct |
| Oct. 9, 2020 | LGND | Common Stock | 27,034,437 | Direct |
| May 7, 2015 | LGND | Common Stock | 4,552,859 | Indirect |
| May 7, 2015 | LGND | Convertible Note (convertible into common stock)→ Common Stock | — | Direct |